ERCC1, PARP-1, and AQP1 as predictive biomarkers in colon cancer patients receiving adjuvant chemotherapy
{{output}}
Background: The recognition of high-risk colon cancer patients prone to chemoresistant and recurrent disease is a challenge. Objectives: We aim... ...
